North America IVD Market Overview:

The North America IVD Market is accounted for $20,886 million in 2016, and is estimated to reach $27.820 million by 2023, growing at a CAGR of 4.1% during the analysis period 2017-2023.

IVD products are those agents, instruments, and systems utilized to examine samples such as blood, urine, stool, tissues, and other body fluids. These samples are derived from the human body to detect diseases, conditions, and infections. The tests can be performed in standalone laboratory, and hospital-based laboratory. IVD utilizes several techniques, such as polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry for test sample preparation to detect diseases.

Get more information on this report : Request Sample Pages

Rise in incidence & prevalence of chronic diseases, technological advancements in testing techniques, and the increase in healthcare expenditure fuel the market growth during the analysis period. However, stringent regulatory policies and unclear reimbursement policies restrict the growth.

North America IVD Market Segmentation

Get more information on this report : Request Sample Pages

Segment Review

Based on product type, the market is categorized into reagents, instruments, and software & services. The reagent segment accounted for the highest market share in 2016, and the software and services is expected to grow at the highest growth rate during the forecast period. The growth of the reagent market is attributed to the recent introduction of new novel reagents and wide availability of effective and cost-efficient reagents. On the basis of technique, the immunodiagnostics segment captured the highest market share in 2016, due to the increase in demand of personalized medicines. On the basis of application, infectious diseases segment captured the highest market share in 2016, because of the increase in prevalence of infectious diseases and rise in healthcare awareness among the population. Based on end users, the standalone laboratory segment captured the highest market share in 2016, primarily due to non-availability of complex tests in hospitals and commercial clinics.

Top Investment Pocket

Get more information on this report : Request Sample Pages

Country Wise Review

By geography, the North America IVD market is analyzed across the U.S., Canada, and Mexico. The U.S. accounted for the highest market share in 2016, followed by Canada. Mexico is anticipated to witness the highest growth rate during the forecast period.

U.S. IVD Market ($Million), 2017-2023

Get more information on this report : Request Sample Pages

Increase in Prevalence of Infectious Diseases

IVD market in North America is its growth stage due to increase in incidences of infectious diseases such as tuberculosis, HIV, AIDS, malaria, rabies, ebola virus, and pertussis. Increase in incidences of infectious diseases predominantly drives the IVD market.

Rising Aging Population

The North America IVD market is on an increase due to growth in geriatric population as the number in volume of chronic and infectious diseases increases. From 2000 and 2050, the number of older people is projected to increase by 135%. In addition, the population aged 85 and above is projected to increase by 350%. Creating healthcare awareness among the masses as well as adoption of advance in vitro techniques for disease diagnosis is another major opportunity for the growth of the market in North America. The IVD market is affected by the taxes implied on the IVD instruments, as it adds up the marked cost.

Key Market Benefits:

• The study provides an in-depth analysis of the North America IVD market with current trends and future estimations to elucidate the imminent investment pockets.
• The report provides a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities
• Extensive analysis by technology and application helps understand various trends and prevailing opportunities in the respective market
• Comprehensive analysis of all geographical regions is provided, which determines the main opportunities in these geographies
• Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which predict the competitive outlook of the North America IVD

 Key Market Segments

• By Product Type
  • Reagents
  • Instruments
  • Software and Services
• By Techniques
  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Chemiluminescence Immunoassays (CLIAS)
    • Fluorescence Immunoassays (FIAS)
    • Colorimetric Immunoassays (CIS)
    • Rapid Tests
    • Enzyme-Linked Immunospot Assays (ELISPOT)
    • Radioimmunoassay
    • Western Blot
  • Blood Testing
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA Diagnostics
    • Microarrays
    • Others
  • Tissue Diagnostics
    • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Renal Profile
    • Electrolyte Panel
    • Specialty Chemicals
  • Other IVD Techniques
• By Application
  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases
  • Gastrointestinal Diseases
  • Other Indications
• By End Users
  • Standalone Laboratory
  • Hospitals
  • Academic and Medical Schools
  • Point of Care Testing
  • Others
• By Country
  • U.S.
  • Canada
  • Mexico

 
Key Market Players

• JOHNSON & JOHNSON
• BIO-RAD LABORATORIES
• BIOMERIEUX
• ALERE INC.
• SYSMEX CORPORATION
• BAYER AG
• DANAHER CORPORATION
• BECTON DICKINSON AND COMPANY
• F. HOFFMANN-LA ROCHE AG
• THERMO FISHER SCIENTIFIC INC.

CHAPTER 1 INTRODUCTION

1.1 REPORT DESCRIPTION
1.2 KEY BENEFITS
1.3 KEY MARKET SEGMENTS
1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1 MARKET DEFINITION AND SCOPE
3.2 KEY FINDINGS

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 PORTER’S FIVE FORCES ANALYSIS

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 MARKET SHARE ANALYSIS, 2016
3.5 MARKET DYNAMICS

3.5.1 Drivers

3.5.1.1 Increasing incidence of chronic and infectious diseases
3.5.1.2 Technological advancements in IVD
3.5.1.3 Emergence of minimal invasive technologies
3.5.1.4 Increasing government expenditures on healthcare
3.5.1.5 Increase in popularity of personalized medicine approach

3.5.2 Restraint

3.5.2.1 Unclear reimbursement policies
3.5.2.2 Stringent regulatory policies

3.5.3 Opportunity

3.5.3.1 Potential opportunities for outsourcing
3.5.3.2 Convergence of new technologies

CHAPTER 4 IVD MARKET, BY PRODUCT TYPE

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 REAGENTS

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 INSTRUMENTS

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 SOFTWARE AND SERVICES

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

CHAPTER 5 IVD MARKET, BY TECHNIQUE

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 IMMUNODIAGNOSTICS

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence immunoassay (CLIA)

5.2.4.2.1 Market size and forecast

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 Market size and forecast

5.2.4.4 Colorimetric immunoassay (CI)

5.2.4.4.1 Market size and forecast

5.2.5 Rapid tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-linked immunospot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 BLOOD TESTING

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 MOLECULAR DIAGNOSTICS

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize chain reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal nucleic acid technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 TISSUE DIAGNOSTICS

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 CLINICAL CHEMISTRY

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 OTHER IVD TECHNIQUES

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

CHAPTER 6 IVD MARKET, BY APPLICATION

6.1 INFECTIOUS DISEASES

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 CANCER

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 CARDIAC DISEASES

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 IMMUNE SYSTEM DISORDERS

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 NEPHROLOGICAL DISEASES

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 GASTROINTESTINAL DISEASES

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 OTHERS INDICATIONS

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

CHAPTER 7 IVD MARKET BY END USERS

7.1 STANDALONE LABORATORIES

7.1.1 Market size and forecast

7.2 HOSPITALS

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 ACADEMIC AND MEDICAL SCHOOLS

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 POINT OF CARE TESTING

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 OTHERS END-USER

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

CHAPTER 8 NORTH AMERICA IVD MARKET

8.1 Key market trends
8.2 Key growth factors and opportunities
8.3 Market size and forecast
8.4 U.S.

8.4.1 Market size and forecast

8.5 Canada

8.5.1 Market size and forecast

8.6 Mexico

8.4.6.1 Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1 THERMO FISHER SCIENTIFIC INC.

9.1.1 Company overview
9.1.2 Business performance
9.1.3 Key strategies and development

9.2 ALERE INC.

9.2.1 Company overview
9.2.2 Business performance
9.2.3 Key strategies and developments

9.3 BIOMERIEUX

9.3.1 Company overview
9.3.2 Business performance
9.3.3 Key strategies and developments

9.4 DANAHER CORPORATION

9.4.1 Company overview
9.4.2 Business performance
9.4.3 Key strategies and development

9.5 F. HOFFMANN-LA ROCHE AG

9.5.1 Company overview
9.5.2 Business performance
9.5.3 Key strategies and developments

9.6 BECTON DICKINSON AND COMPANY

9.6.1 Company overview
9.6.2 Business performance
9.6.3 Key strategies and development

9.7 BIO-RAD LABORATORIES

9.7.1 Company overview
9.7.2 Business performance
9.7.3 Key strategies and developments

9.8 BAYER AG

9.8.1 Company overview
9.8.2 Business performance
9.8.3 Key strategies and development

9.9 SYSMEX CORPORATION

9.9.1 Company overview
9.9.2 Business performance
9.9.3 Key strategies and developments

9.10 JOHNSON & JOHNSON

9.10.1 Company overview
9.10.2 Business performance
9.10.3 Key strategies and development

List of Tables

TABLE 1 INCIDENCE OF DISEASES
TABLE 2 NORTH AMERICA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3 NORTH AMERICA IVD REAGENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 4 NORTH AMERICA IVD INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 5 NORTH AMERICA IVD SOFTWARE & SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 6 NORTH AMERICA IVD MARKET BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 7 NORTH AMERICA IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TYPES, 2016-2023 ($MILLION)
TABLE 8 NORTH AMERICA IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY COUNTRY,2016-2023 ($MILLION)
TABLE 9 NORTH AMERICA IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)
TABLE 10 NORTH AMERICA IVD BLOOD TESTING TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11 NORTH AMERICA IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12 NORTH AMERICA IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 13 NORTH AMERICA IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 14 NORTH AMERICA IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 15 NORTH AMERICA OTHER IVD TECHNIQUES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 16 NORTH AMERICA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17 NORTH AMERICA IVD INFECTIOUS DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18 NORTH AMERICA IVD CANCER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19 NORTH AMERICA IVD CARDIAC DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20 NORTH AMERICA IVD IMMUNE SYSTEM DISORDER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 21 NORTH AMERICA IVD NEPHROLOGICAL DISEASES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 22 NORTH AMERICA IVD GASTROINTESTINAL DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23 NORTH AMERICA IVD OTHER INDICATION MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24 NORTH AMERICA IVD MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 25 NORTH AMERICA IVD STANDALONE LABORATORIES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26 NORTH AMERICA IVD HOSPITALS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27 NORTH AMERICA IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28 NORTH AMERICA IVD POINT OF CARE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29 NORTH AMERICA IVD OTHER END-USER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30 NORTH AMERICA IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 31 NORTH AMERICA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 32 NORTH AMERICA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 33 NORTH AMERICA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34 NORTH AMERICA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 35 U.S. IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 36 U.S. IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 37 U.S. IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 38 U.S. IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 39 CANADA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 40 CANADA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 41 CANADA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 42 CANADA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 43 MEXICO IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 44 MEXICO IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 45 MEXICO IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 46 THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT
TABLE 47 ALERE INC. COMPANY SNAPSHOT
TABLE 48 BIOMERIEUX COMPANY SNAPSHOT
TABLE 49 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 50 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 51 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 52 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 53 BAYER AG COMPANY SNAPSHOT
TABLE 54 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 55 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT

List of Figures

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 TOP INVESTMENT POCKETS
FIGURE 3 TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS
FIGURE 6 MARKET SHARE ANALYSIS: IVD MARKET, 2016
FIGURE 7 NORTH AMERICA CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2016-2023 ($MILLION)
FIGURE 8 NORTH AMERICA FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2016-2023 ($MILLION)
FIGURE 9 NORTH AMERICA COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2016-2023 ($MILLION)
FIGURE 10 NORTH AMERICA RAPID TESTS MARKET, 2016-2023 ($MILLION)
FIGURE 11 NORTH AMERICA ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2016-2023 ($MILLION)
FIGURE 12 NORTH AMERICA RADIOIMMUNOASSAY (RIA) MARKET, 2016-2023 ($MILLION)
FIGURE 13 NORTH AMERICA WESTERN BLOT TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 14 NORTH AMERICA POLYMERIZE CHAIN REACTION PCR MARKET, 2016-2023 ($MILLION)
FIGURE 15 NORTH AMERICA ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2016-2023 ($MILLION)
FIGURE 16 NORTH AMERICA HYBRIDIZATION MARKET, 2016-2023 ($MILLION)
FIGURE 17 NORTH AMERICA DNA DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 18 NORTH AMERICA MICROARRAY MARKET, 2016-2023 ($MILLION)
FIGURE 19 NORTH AMERICA OTHER MOLECULAR DIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 20 NORTH AMERICA BASIC METABOLIC PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 21 NORTH AMERICA LIVER PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 22 NORTH AMERICA RENAL PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 23 NORTH AMERICA LIPID PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 24 NORTH AMERICA THYROID FUNCTION PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 25 NORTH AMERICA ELECTROLYTE PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 26 NORTH AMERICA SPECIALITY CHEMICALS MARKET, 2016-2023 ($MILLION)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 28 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 30 ALERE INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 31 ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 32 ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 33 BIOMERIEUX REVENUE: 2014-2016 ($MILLION)
FIGURE 34 BIOMERIEUX: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 35 BIOMERIEUX: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 36 DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 37 DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 38 DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 39 ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)
FIGURE 40 ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 41 BECTON, DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)
FIGURE 42 BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)
FIGURE 43 BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 44 BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)
FIGURE 45 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 46 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 47 BAYER AG: REVENUE, 2014-2016 ($MILLION)
FIGURE 48 BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 49 SYSMEX CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 50 SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 51 SYSMEX CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 52 JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)
FIGURE 53 JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 54 JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (%)(2016)